Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats

• Egile Nagusiak: Mohammed Fouad Shalaby, MD (Egilea), Hekma A. Abd El Latif, PhD (Egilea), Mohamed El Yamani, PhD (Egilea), May Ahmed Galal, PhD (Egilea), Sherifa Kamal, PhD (Egilea), Ikhlas Sindi, PhD (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2021-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

ABSTRACT: Background: Although dopamine D2 receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia, there is an identified relationship between the utilization of D2-like R agonists and the progress of myocardi...